Is  ||| S:0 E:3 ||| VBZ
thenar  ||| S:3 E:10 ||| JJ
tissue  ||| S:10 E:17 ||| NN
hemoglobin  ||| S:17 E:28 ||| NN
oxygen  ||| S:28 E:35 ||| NN
saturation  ||| S:35 E:46 ||| NN
in  ||| S:46 E:49 ||| IN
septic  ||| S:49 E:56 ||| JJ
shock  ||| S:56 E:62 ||| NN
related  ||| S:62 E:70 ||| VBN
to  ||| S:70 E:73 ||| TO
macrohemodynamic  ||| S:73 E:90 ||| VB
variables  ||| S:90 E:100 ||| NNS
and  ||| S:100 E:104 ||| CC
outcome ||| S:104 E:111 ||| NN
?  ||| S:111 E:113 ||| .
The  ||| S:113 E:117 ||| DT
study  ||| S:117 E:123 ||| NN
objectives  ||| S:123 E:134 ||| NNS
were  ||| S:134 E:139 ||| VBD
to  ||| S:139 E:142 ||| TO
evaluate  ||| S:142 E:151 ||| VB
septic  ||| S:151 E:158 ||| FW
shock-induced  ||| S:158 E:172 ||| FW
alterations  ||| S:172 E:184 ||| FW
in  ||| S:184 E:187 ||| FW
skeletal  ||| S:187 E:196 ||| FW
muscle  ||| S:196 E:203 ||| FW
hemoglobin  ||| S:203 E:214 ||| FW
oxygenation  ||| S:214 E:226 ||| FW
saturation  ||| S:226 E:237 ||| FW
( ||| S:237 E:238 ||| -LRB-
StO2 ||| S:238 E:242 ||| NNP
)  ||| S:242 E:244 ||| -RRB-
using  ||| S:244 E:250 ||| VBG
near-infrared  ||| S:250 E:264 ||| JJ
spectroscopy  ||| S:264 E:277 ||| NNS
( ||| S:277 E:278 ||| -LRB-
NIRS ||| S:278 E:282 ||| NNP
)  ||| S:282 E:284 ||| -RRB-
and  ||| S:284 E:288 ||| CC
forearm  ||| S:288 E:296 ||| JJ
skin  ||| S:296 E:301 ||| NN
blood  ||| S:301 E:307 ||| NN
flow  ||| S:307 E:312 ||| NN
velocity  ||| S:312 E:321 ||| NN
using  ||| S:321 E:327 ||| VBG
laser  ||| S:327 E:333 ||| NN
Doppler  ||| S:333 E:341 ||| NNP
( ||| S:341 E:342 ||| -LRB-
LD ||| S:342 E:344 ||| NNP
)  ||| S:344 E:346 ||| -RRB-
to  ||| S:346 E:349 ||| TO
determine  ||| S:349 E:359 ||| VB
the  ||| S:359 E:363 ||| DT
relationship  ||| S:363 E:376 ||| NN
of  ||| S:376 E:379 ||| IN
macroperfusion  ||| S:379 E:394 ||| NN
and  ||| S:394 E:398 ||| CC
microperfusion  ||| S:398 E:413 ||| JJ
parameters ||| S:413 E:423 ||| NNS
,  ||| S:423 E:425 ||| ,
and  ||| S:425 E:429 ||| CC
to  ||| S:429 E:432 ||| TO
test  ||| S:432 E:437 ||| VB
the  ||| S:437 E:441 ||| DT
relationship  ||| S:441 E:454 ||| NN
of  ||| S:454 E:457 ||| IN
the  ||| S:457 E:461 ||| DT
worst  ||| S:461 E:467 ||| JJS
NIRS  ||| S:467 E:472 ||| JJ
parameters  ||| S:472 E:483 ||| NNS
during  ||| S:483 E:490 ||| IN
the  ||| S:490 E:494 ||| DT
first  ||| S:494 E:500 ||| JJ
24  ||| S:500 E:503 ||| CD
hours  ||| S:503 E:509 ||| NNS
of  ||| S:509 E:512 ||| IN
shock  ||| S:512 E:518 ||| NN
with  ||| S:518 E:523 ||| IN
28-day  ||| S:523 E:530 ||| CD
prognosis ||| S:530 E:539 ||| NN
.  ||| S:539 E:541 ||| .
A  ||| S:541 E:543 ||| DT
prospective ||| S:543 E:554 ||| JJ
,  ||| S:554 E:556 ||| ,
observational  ||| S:556 E:570 ||| JJ
study  ||| S:570 E:576 ||| NN
was  ||| S:576 E:580 ||| VBD
performed  ||| S:580 E:590 ||| VBN
in  ||| S:590 E:593 ||| IN
a  ||| S:593 E:595 ||| DT
21-bed  ||| S:595 E:602 ||| JJ
university  ||| S:602 E:613 ||| NN
hospital  ||| S:613 E:622 ||| NN
surgical  ||| S:622 E:631 ||| JJ
intensive  ||| S:631 E:641 ||| JJ
care  ||| S:641 E:646 ||| NN
unit ||| S:646 E:650 ||| NN
.  ||| S:650 E:652 ||| .
Forty-three  ||| S:652 E:664 ||| JJ
septic  ||| S:664 E:671 ||| JJ
shock  ||| S:671 E:677 ||| NN
patients  ||| S:677 E:686 ||| NNS
with  ||| S:686 E:691 ||| IN
at  ||| S:691 E:694 ||| IN
least  ||| S:694 E:700 ||| JJS
another  ||| S:700 E:708 ||| DT
organ  ||| S:708 E:714 ||| NN
failure  ||| S:714 E:722 ||| NN
underwent  ||| S:722 E:732 ||| VBD
a  ||| S:732 E:734 ||| DT
3-minute ||| S:734 E:742 ||| NNP
,  ||| S:742 E:744 ||| ,
upper  ||| S:744 E:750 ||| JJ
arm  ||| S:750 E:754 ||| NN
( ||| S:754 E:755 ||| -LRB-
brachial  ||| S:755 E:764 ||| JJ
artery ||| S:764 E:770 ||| NN
)  ||| S:770 E:772 ||| -RRB-
vascular  ||| S:772 E:781 ||| JJ
occlusion  ||| S:781 E:791 ||| JJ
test  ||| S:791 E:796 ||| NN
( ||| S:796 E:797 ||| -LRB-
VOT ||| S:797 E:800 ||| NNP
) ||| S:800 E:801 ||| -RRB-
.  ||| S:801 E:803 ||| .
Microperfusion  ||| S:803 E:818 ||| JJ
parameters  ||| S:818 E:829 ||| NNS
( ||| S:829 E:830 ||| -LRB-
thenar  ||| S:830 E:837 ||| FW
eminence  ||| S:837 E:846 ||| FW
StO2  ||| S:846 E:851 ||| FW
and  ||| S:851 E:855 ||| CC
forearm  ||| S:855 E:863 ||| JJ
LD  ||| S:863 E:866 ||| NNP
skin  ||| S:866 E:871 ||| NN
blood  ||| S:871 E:877 ||| NN
flow ||| S:877 E:881 ||| NN
)  ||| S:881 E:883 ||| -RRB-
were  ||| S:883 E:888 ||| VBD
collected  ||| S:888 E:898 ||| VBN
on  ||| S:898 E:901 ||| IN
days  ||| S:901 E:906 ||| NNS
1 ||| S:906 E:907 ||| CD
,  ||| S:907 E:909 ||| ,
2  ||| S:909 E:911 ||| CD
and  ||| S:911 E:915 ||| CC
3 ||| S:915 E:916 ||| CD
,  ||| S:916 E:918 ||| ,
before  ||| S:918 E:925 ||| IN
( ||| S:925 E:926 ||| -LRB-
baseline  ||| S:926 E:935 ||| NN
StO2  ||| S:935 E:940 ||| NN
and  ||| S:940 E:944 ||| CC
LD  ||| S:944 E:947 ||| NNP
values ||| S:947 E:953 ||| NNS
)  ||| S:953 E:955 ||| -RRB-
and  ||| S:955 E:959 ||| CC
during  ||| S:959 E:966 ||| IN
the  ||| S:966 E:970 ||| DT
3-minute  ||| S:970 E:979 ||| NNP
VOT  ||| S:979 E:983 ||| NNP
with  ||| S:983 E:988 ||| IN
calculation  ||| S:988 E:1000 ||| NN
of  ||| S:1000 E:1003 ||| IN
occlusion  ||| S:1003 E:1013 ||| NN
and  ||| S:1013 E:1017 ||| CC
reperfusion  ||| S:1017 E:1029 ||| JJ
slopes  ||| S:1029 E:1036 ||| NNS
for  ||| S:1036 E:1040 ||| IN
StO2  ||| S:1040 E:1045 ||| NNP
and  ||| S:1045 E:1049 ||| CC
LD ||| S:1049 E:1051 ||| NNP
.  ||| S:1051 E:1053 ||| .
Daily  ||| S:1053 E:1059 ||| NNP
Sequential  ||| S:1059 E:1070 ||| NNP
Organ  ||| S:1070 E:1076 ||| NNP
Failure  ||| S:1076 E:1084 ||| NNP
Assessment  ||| S:1084 E:1095 ||| NNP
( ||| S:1095 E:1096 ||| -LRB-
SOFA ||| S:1096 E:1100 ||| NNP
)  ||| S:1100 E:1102 ||| -RRB-
score ||| S:1102 E:1107 ||| NN
,  ||| S:1107 E:1109 ||| ,
macrohemodynamic  ||| S:1109 E:1126 ||| JJ
parameters  ||| S:1126 E:1137 ||| NNS
( ||| S:1137 E:1138 ||| -LRB-
systolic  ||| S:1138 E:1147 ||| JJ
arterial  ||| S:1147 E:1156 ||| JJ
blood  ||| S:1156 E:1162 ||| NN
pressure ||| S:1162 E:1170 ||| NN
,  ||| S:1170 E:1172 ||| ,
cardiac  ||| S:1172 E:1180 ||| JJ
output  ||| S:1180 E:1187 ||| NN
( ||| S:1187 E:1188 ||| -LRB-
pulmonary  ||| S:1188 E:1198 ||| JJ
artery  ||| S:1198 E:1205 ||| NN
catheter  ||| S:1205 E:1214 ||| NN
or  ||| S:1214 E:1217 ||| CC
transesophageal  ||| S:1217 E:1233 ||| JJ
Doppler ||| S:1233 E:1240 ||| NNP
) ||| S:1240 E:1241 ||| -RRB-
,  ||| S:1241 E:1243 ||| ,
mixed  ||| S:1243 E:1249 ||| JJ
venous  ||| S:1249 E:1256 ||| JJ
oxygen  ||| S:1256 E:1263 ||| NN
saturation  ||| S:1263 E:1274 ||| NNS
( ||| S:1274 E:1275 ||| -LRB-
pulmonary  ||| S:1275 E:1285 ||| JJ
artery  ||| S:1285 E:1292 ||| NN
or  ||| S:1292 E:1295 ||| CC
superior  ||| S:1295 E:1304 ||| JJ
vena  ||| S:1304 E:1309 ||| JJ
cava  ||| S:1309 E:1314 ||| JJ
catheter ||| S:1314 E:1322 ||| NN
) ||| S:1322 E:1323 ||| -RRB-
)  ||| S:1323 E:1325 ||| -RRB-
and  ||| S:1325 E:1329 ||| CC
metabolic  ||| S:1329 E:1339 ||| JJ
parameters  ||| S:1339 E:1350 ||| NNS
( ||| S:1350 E:1351 ||| -LRB-
pH ||| S:1351 E:1353 ||| NNP
,  ||| S:1353 E:1355 ||| ,
base  ||| S:1355 E:1360 ||| NN
excess ||| S:1360 E:1366 ||| NN
,  ||| S:1366 E:1368 ||| ,
lactate ||| S:1368 E:1375 ||| CD
)  ||| S:1375 E:1377 ||| -RRB-
were  ||| S:1377 E:1382 ||| VBD
determined ||| S:1382 E:1392 ||| VBN
.  ||| S:1392 E:1394 ||| .
Baseline  ||| S:1394 E:1403 ||| NNP
StO2  ||| S:1403 E:1408 ||| NNP
( ||| S:1408 E:1409 ||| -LRB-
82 ||| S:1409 E:1411 ||| CD
%  ||| S:1411 E:1413 ||| NN
( ||| S:1413 E:1414 ||| -LRB-
75  ||| S:1414 E:1417 ||| CD
to  ||| S:1417 E:1420 ||| TO
88 ||| S:1420 E:1422 ||| CD
)  ||| S:1422 E:1424 ||| -RRB-
vs.  ||| S:1424 E:1428 ||| IN
89 ||| S:1428 E:1430 ||| CD
%  ||| S:1430 E:1432 ||| NN
( ||| S:1432 E:1433 ||| -LRB-
85  ||| S:1433 E:1436 ||| CD
to  ||| S:1436 E:1439 ||| TO
92 ||| S:1439 E:1441 ||| CD
) ||| S:1441 E:1442 ||| -RRB-
,  ||| S:1442 E:1444 ||| ,
P  ||| S:1444 E:1446 ||| NN
=  ||| S:1446 E:1448 ||| SYM
0.04 ||| S:1448 E:1452 ||| CD
)  ||| S:1452 E:1454 ||| -RRB-
and  ||| S:1454 E:1458 ||| CC
reperfusion  ||| S:1458 E:1470 ||| JJ
slope  ||| S:1470 E:1476 ||| NN
( ||| S:1476 E:1477 ||| -LRB-
2.79 ||| S:1477 E:1481 ||| CD
% ||| S:1481 E:1482 ||| NN
/ ||| S:1482 E:1483 ||| CD
second  ||| S:1483 E:1490 ||| JJ
( ||| S:1490 E:1491 ||| -LRB-
1.75  ||| S:1491 E:1496 ||| CD
to  ||| S:1496 E:1499 ||| TO
4.32 ||| S:1499 E:1503 ||| CD
)  ||| S:1503 E:1505 ||| -RRB-
vs.  ||| S:1505 E:1509 ||| IN
9.35 ||| S:1509 E:1513 ||| CD
% ||| S:1513 E:1514 ||| NN
/ ||| S:1514 E:1515 ||| CD
second  ||| S:1515 E:1522 ||| JJ
( ||| S:1522 E:1523 ||| -LRB-
8.32  ||| S:1523 E:1528 ||| CD
to  ||| S:1528 E:1531 ||| TO
11.57 ||| S:1531 E:1536 ||| CD
) ||| S:1536 E:1537 ||| -RRB-
,  ||| S:1537 E:1539 ||| ,
P  ||| S:1539 E:1541 ||| NNP
< ||| S:1541 E:1543 ||| SYM
0.0001 ||| S:1543 E:1549 ||| NNP
)  ||| S:1549 E:1551 ||| -RRB-
were  ||| S:1551 E:1556 ||| VBD
lower  ||| S:1556 E:1562 ||| JJR
in  ||| S:1562 E:1565 ||| IN
septic  ||| S:1565 E:1572 ||| JJ
shock  ||| S:1572 E:1578 ||| NN
patients  ||| S:1578 E:1587 ||| NNS
than  ||| S:1587 E:1592 ||| IN
in  ||| S:1592 E:1595 ||| IN
healthy  ||| S:1595 E:1603 ||| JJ
volunteers ||| S:1603 E:1613 ||| NNS
.  ||| S:1613 E:1615 ||| .
StO2  ||| S:1615 E:1620 ||| FW
reperfusion  ||| S:1620 E:1632 ||| FW
slope  ||| S:1632 E:1638 ||| FW
correlated  ||| S:1638 E:1649 ||| FW
with  ||| S:1649 E:1654 ||| FW
occlusion  ||| S:1654 E:1664 ||| FW
slope  ||| S:1664 E:1670 ||| FW
( ||| S:1670 E:1671 ||| -LRB-
P  ||| S:1671 E:1673 ||| NNP
< ||| S:1673 E:1675 ||| SYM
0.0001 ||| S:1675 E:1681 ||| NNP
) ||| S:1681 E:1682 ||| -RRB-
,  ||| S:1682 E:1684 ||| ,
cardiac  ||| S:1684 E:1692 ||| JJ
output  ||| S:1692 E:1699 ||| NN
( ||| S:1699 E:1700 ||| -LRB-
P  ||| S:1700 E:1702 ||| NN
=  ||| S:1702 E:1704 ||| SYM
0.01 ||| S:1704 E:1708 ||| CD
)  ||| S:1708 E:1710 ||| -RRB-
and  ||| S:1710 E:1714 ||| CC
LD  ||| S:1714 E:1717 ||| NNP
reperfusion  ||| S:1717 E:1729 ||| FW
slope  ||| S:1729 E:1735 ||| FW
( ||| S:1735 E:1736 ||| -LRB-
P  ||| S:1736 E:1738 ||| NN
=  ||| S:1738 E:1740 ||| SYM
0.08 ||| S:1740 E:1744 ||| CD
) ||| S:1744 E:1745 ||| -RRB-
,  ||| S:1745 E:1747 ||| ,
and  ||| S:1747 E:1751 ||| CC
negatively  ||| S:1751 E:1762 ||| RB
with  ||| S:1762 E:1767 ||| IN
lactate  ||| S:1767 E:1775 ||| JJ
level  ||| S:1775 E:1781 ||| NN
( ||| S:1781 E:1782 ||| -LRB-
P  ||| S:1782 E:1784 ||| NN
=  ||| S:1784 E:1786 ||| SYM
0.04 ||| S:1786 E:1790 ||| CD
) ||| S:1790 E:1791 ||| -RRB-
.  ||| S:1791 E:1793 ||| .
The  ||| S:1793 E:1797 ||| DT
worst  ||| S:1797 E:1803 ||| JJS
StO2  ||| S:1803 E:1808 ||| CD
reperfusion  ||| S:1808 E:1820 ||| JJ
slope  ||| S:1820 E:1826 ||| NN
during  ||| S:1826 E:1833 ||| IN
the  ||| S:1833 E:1837 ||| DT
first  ||| S:1837 E:1843 ||| JJ
day  ||| S:1843 E:1847 ||| NN
of  ||| S:1847 E:1850 ||| IN
shock  ||| S:1850 E:1856 ||| NN
was  ||| S:1856 E:1860 ||| VBD
lower  ||| S:1860 E:1866 ||| JJR
in  ||| S:1866 E:1869 ||| IN
nonsurvivors  ||| S:1869 E:1882 ||| NN
than  ||| S:1882 E:1887 ||| IN
in  ||| S:1887 E:1890 ||| IN
survivors  ||| S:1890 E:1900 ||| NNS
( ||| S:1900 E:1901 ||| -LRB-
P  ||| S:1901 E:1903 ||| NN
=  ||| S:1903 E:1905 ||| SYM
0.003 ||| S:1905 E:1910 ||| CD
)  ||| S:1910 E:1912 ||| -RRB-
and  ||| S:1912 E:1916 ||| CC
improved  ||| S:1916 E:1925 ||| VBD
significantly  ||| S:1925 E:1939 ||| RB
the  ||| S:1939 E:1943 ||| DT
predictive  ||| S:1943 E:1954 ||| JJ
value  ||| S:1954 E:1960 ||| NN
of  ||| S:1960 E:1963 ||| IN
Simplified  ||| S:1963 E:1974 ||| NNP
Acute  ||| S:1974 E:1980 ||| NNP
Physiology  ||| S:1980 E:1991 ||| NNP
Score  ||| S:1991 E:1997 ||| NNP
II  ||| S:1997 E:2000 ||| NNP
and  ||| S:2000 E:2004 ||| CC
SOFA  ||| S:2004 E:2009 ||| NNP
scores ||| S:2009 E:2015 ||| NNS
.  ||| S:2015 E:2017 ||| .
The  ||| S:2017 E:2021 ||| DT
alteration  ||| S:2021 E:2032 ||| NN
of  ||| S:2032 E:2035 ||| IN
StO2  ||| S:2035 E:2040 ||| CD
reperfusion  ||| S:2040 E:2052 ||| JJ
slope  ||| S:2052 E:2058 ||| NN
in  ||| S:2058 E:2061 ||| IN
septic  ||| S:2061 E:2068 ||| JJ
shock  ||| S:2068 E:2074 ||| NN
patients  ||| S:2074 E:2083 ||| NNS
compared  ||| S:2083 E:2092 ||| VBN
with  ||| S:2092 E:2097 ||| IN
healthy  ||| S:2097 E:2105 ||| JJ
volunteers  ||| S:2105 E:2116 ||| NNS
was  ||| S:2116 E:2120 ||| VBD
related  ||| S:2120 E:2128 ||| VBN
with  ||| S:2128 E:2133 ||| IN
macrohemodynamic ||| S:2133 E:2149 ||| NN
,  ||| S:2149 E:2151 ||| ,
microhemodynamic  ||| S:2151 E:2168 ||| NN
and  ||| S:2168 E:2172 ||| CC
metabolic  ||| S:2172 E:2182 ||| JJ
parameters ||| S:2182 E:2192 ||| NNS
.  ||| S:2192 E:2194 ||| .
The  ||| S:2194 E:2198 ||| DT
addition  ||| S:2198 E:2207 ||| NN
of  ||| S:2207 E:2210 ||| IN
the  ||| S:2210 E:2214 ||| DT
worst  ||| S:2214 E:2220 ||| JJS
value  ||| S:2220 E:2226 ||| NN
of  ||| S:2226 E:2229 ||| IN
the  ||| S:2229 E:2233 ||| DT
day  ||| S:2233 E:2237 ||| NN
1  ||| S:2237 E:2239 ||| CD
StO2  ||| S:2239 E:2244 ||| CD
reperfusion  ||| S:2244 E:2256 ||| JJ
slope  ||| S:2256 E:2262 ||| NN
improved  ||| S:2262 E:2271 ||| VBD
the  ||| S:2271 E:2275 ||| DT
outcome  ||| S:2275 E:2283 ||| NN
prediction  ||| S:2283 E:2294 ||| NN
of  ||| S:2294 E:2297 ||| IN
Simplified  ||| S:2297 E:2308 ||| NNP
Acute  ||| S:2308 E:2314 ||| NNP
Physiology  ||| S:2314 E:2325 ||| NNP
Score  ||| S:2325 E:2331 ||| NNP
II  ||| S:2331 E:2334 ||| NNP
and  ||| S:2334 E:2338 ||| CC
SOFA  ||| S:2338 E:2343 ||| NNP
scores ||| S:2343 E:2349 ||| NNS
.  ||| S:2349 E:2351 ||| .
